APP and Alzheimer disease: Interestingly, astrocytes in the APP/PS1 AD mouse model were also shown to be implicated in disease mechanisms by contributing to neuronal‐glial network dysfunction, which can be ameliorated by P2Y1 receptor antagonists (Reichenbach et al., 2018).